Literature DB >> 7397071

A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood.

C M Kaye, M G Sankey, L A Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7397071      PMCID： PMC1429966          DOI： 10.1111/j.1365-2125.1980.tb05856.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  The isolation and identification of the urinary oxidative metabolites of metronidazole in man.

Authors:  J E Stambaugh; L G Feo; R W Manthei
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

2.  Determination of metronidazole and tinidazole in plasma and feces by high-performance liquid chromatography.

Authors:  K Lanbeck; B Lindström
Journal:  J Chromatogr       Date:  1979-01-01

3.  Determination of metronidazole and misonidazole and their metabolites in plasma and urine by high-performance liquid chromatography.

Authors:  R A Marques; B Stafford; N Flynn; W Sadée
Journal:  J Chromatogr       Date:  1978-07-01

4.  Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration.

Authors:  L A Wheeler; M De Meo; M Halula; L George; P Heseltine
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

5.  Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography.

Authors:  A Gulaid; G W Houghton; O R Lewellen; J Smith; P S Thorne
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

6.  Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose.

Authors:  G W Houghton; P S Thorne; J Smith; R Templeton; J Collier
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

Review 7.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

8.  Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.

Authors:  P Workman; C R Wiltshire; P N Plowman; N M Bleehen
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640
  8 in total
  16 in total

1.  Disposition of intravenous metronidazole in Asian surgical patients.

Authors:  T Y Ti; H S Lee; Y M Khoo
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

2.  Antipyrine and metronidazole metabolism during occupational exposure to gasoline.

Authors:  M Døssing; S Loft; J Sonne; E Schroeder
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

3.  A new bioerodible polymer insert for the controlled release of metronidazole.

Authors:  K A Gates; H Grad; P Birek; P I Lee
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

4.  Influence of dose and route of administration on disposition of metronidazole and its major metabolites.

Authors:  S Loft; M Døssing; H E Poulsen; J Sonne; K L Olesen; K Simonsen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.

Authors:  T K Daneshmend; M Homeida; C M Kaye; A A Elamin; C J Roberts
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

6.  Plasma metronidazole concentrations after single and repeated vaginal pessary administration.

Authors:  I G Salas-Herrera; M Lawson; A Johnston; P Turner; D M Gott; M J Dennis
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

7.  Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  D R Guay; R C Meatherall; H Baxter; W R Jacyk; B Penner
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  The penetration of metronidazole into synovial fluid.

Authors:  M A Sattar; M G Sankey; M I Cawley; C M Kaye; J E Holt
Journal:  Postgrad Med J       Date:  1982-01       Impact factor: 2.401

9.  Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis.

Authors:  C S Easmon; C A Ison; C M Kaye; R M Timewell; S G Dawson
Journal:  Br J Vener Dis       Date:  1982-08

10.  Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis.

Authors:  D Siegler; C M Kaye; S Reilly; A T Willis; M G Sankey
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.